|7.34||+0.20 / +2.80%|
Data as of 4:00pm ET
|7.34||0.00 / 0.00%|
The 4 analysts offering 12-month price forecasts for Regulus Therapeutics Inc have a median target of 10.00, with a high estimate of 14.00 and a low estimate of 8.00. The median estimate represents a +36.24% increase from the last price of 7.34.
The current consensus among 5 polled investment analysts is to Buy stock in Regulus Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.